Aino Health AB (OSTO:AINO) ROCE %: -2,837.89% (As of Mar. 2026)

What is Aino Health AB ROCE %?

Aino Health AB OSTO:AINO 26 ROCE % is -2,837.89% as of Mar. 2026. GuruFocus rates OSTO:AINO with a GF Score™ of 26/100 and a GF Value™ of kr0.13 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aino Health AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -2,837.89%.

Aino Health AB (OSTO:AINO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aino Health AB ROCE % Related Terms

Aino Health AB ROCE % Historical Data

* Premium members only.

The historical data trend for Aino Health AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aino Health AB ROCE % Chart

Aino Health AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-131.67

-1,373.34

0.00

-1,177.14

Aino Health AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	-2,837.89

26GF Score

Aino Health AB OSTO:AINO

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aino Health AB ROCE % Calculation

Aino Health AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-5.303	/	( ( (9.877 - 10.335)	+	(9.719 - 8.36) )	/ 2 )
	=	-5.303	/	( (-0.458	+	1.359)	/ 2 )
	=	-5.303	/	0.4505
	=	-1,177.14 %

Aino Health AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-8.088	/	( ( (9.719 - 8.36)	+	(7.972 - 8.761) )	/ 2 )
	=	-8.088	/	( ( 1.359	+	-0.789 )	/ 2 )
	=	-8.088	/	0.285
	=	-2,837.89 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -2,837.89% mean?

Aino Health AB (OSTO:AINO) has a ROCE % of -2,837.89% as of Mar. 2026.

Is Aino Health AB's ROCE % too high?

Aino Health AB's current ROCE % is -2,837.89%. Overall, Aino Health AB has a GF Score™ of 26/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Aino Health AB's ROCE % compare to VEEV and BTSG?

Aino Health AB's ROCE % of -2,837.89% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aino Health AB's current ROCE % is -2,837.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aino Health AB stock overvalued right now?

Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Fairly Valued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.13 — trading 1.5% below its estimated fair value. The current ROCE % is -2,837.89%. Aino Health AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current ROCE % is -2,837.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aino Health AB (OSTO:AINO) Overvalued in 2026?

Based on GuruFocus' analysis, Aino Health AB stock appears to be undervalued. The current stock price of kr0.13 is trading 1.5% below its estimated GF Value™ of kr0.13. GuruFocus considers Aino Health AB to be Fairly Valued.

Key valuation signals for OSTO:AINO:

ROCE %: -2,837.89%
GF Value™: kr0.13 vs. price of kr0.13 (1.5% below fair value)
GF Score™: 26/100 with 4 warning signs

No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aino Health AB Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies XSAT:KONT XSAT:SYNT OSTO:PTRK VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY HKSE:02228 PRVA HTFL NSE:IKS SZSE:300253 NSE:SAGILITY OMCL

Other Exchanges 50V:Germany

Address c/o Hermelin & Friends, Kungsgatan 32, Stockholm, SWE, 111 35

Website https://www.ainohealth.com

Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.

26GF Score

Get the complete analysis for OSTO:AINO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.13

Price

kr0.13

GF Value

View OSTO:AINO Analysis

See ROCE % data for all stocks →